✦ LIBER ✦

395 POSTER Phase I study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in patients with advanced malignancies

✍ Scribed by A. Tse; S. Yazji; A. Naing; D. Matthews; G. Schwartz; K. Lawhorn; R. Kurzrock

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

494 A phase I trial of SCH900776, a sele

✍ A. Daud; C. Soon; G. Springett; D. Mendelson; P. Munster; J. Goldman; J. Strosbe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

390 POSTER A Phase I dose-escalation stu

✍ C. Britten; D.C. Smith; L.A. Bui; D.O. Clary; H.I. Hurwitz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase I study of elisidepsin (Irvalec®)

✍ Goldwasser, Francois; Faivre, Sandrine; Alexandre, Jerome; Coronado, Cinthya; Fe 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 267 KB

417 POSTER Phase I study of E7389/Gemcit

✍ R. Goel; L. Vidal; S. Welch; S. Laurie; L. Siu; D. Jonker; R. Srinivasan; L. Wan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase I dose-escalation study of AZD7762

✍ Sausville, Edward; LoRusso, Patricia; Carducci, Michael; Carter, Judith; Quinn, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 560 KB

342 POSTER A phase I dose-escalation and

✍ B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB